Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20

A DuBois, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, Pernille Tine Jensen, F Selle, F Guyon, C Pome, F Lecru, R Zang, E Avall-Lundqvist , J Kim, J Ponce, F Raspagliesi, S Ghaem-Maghami , R Reinthaller, P Harter, J Sehouli

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Volume35
Issue number15 Suppl.
Pages (from-to)5501
Number of pages1
ISSN0732-183X
DOIs
Publication statusPublished - 2017
Event2017 Annual Meeting of the American Society of Clinical Oncology - Mc Cormick Place, Chicago, United States
Duration: 2. Jun 20177. Jun 2017
https://am.asco.org

Conference

Conference2017 Annual Meeting of the American Society of Clinical Oncology
LocationMc Cormick Place
CountryUnited States
CityChicago
Period02/06/201707/06/2017
Internet address

Cite this

DuBois, A., Vergote, I., Ferron, G., Reuss, A., Meier, W., Greggi, S., Jensen, P. T., Selle, F., Guyon, F., Pome, C., Lecru, F., Zang, R., Avall-Lundqvist , E., Kim, J., Ponce, J., Raspagliesi, F., Ghaem-Maghami , S., Reinthaller, R., Harter, P., & Sehouli, J. (2017). Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20. Journal of Clinical Oncology, 35(15 Suppl.), 5501. https://doi.org/10.1200/JCO.2017.35.15_suppl.5501